Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas

European Radiology

Volumn 16, Issue 3, 2006, Pages 598-607

  Metz, Stephan ^a   Lohr, Stefanie ^a   Settles, Marcus ^a   Beer, Ambros ^a   Woertler, Klaus ^a   Rummeny, Ernst J ^a   Daldrup Link, Heike E ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood bone marrow barrier; Ferumoxtran 10; MR

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; RITUXIMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CD34 SELECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG INFUSION; FEMALE; HUMAN; IMAGE ANALYSIS; LEUKAPHERESIS; MALE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMACYTOMA; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW; CONTRAST MEDIA; FEMALE; HUMANS; IRON; LEUKAPHERESIS; LINEAR MODELS; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; TRANSPLANTATION CONDITIONING;

EID: 33746612873     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-0045-9     Document Type: Article

References (25)

1. Frank H, Weissleder R, Brady TJ (1994) Enhancement of MR angiography with iron oxide: Preliminary studies in whole-blood phantom and in animals. AJR 162:209-213
2. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S (1996) Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients. J Comput Assist Tomogr 20:51-55
3. Brasch RC, Shames DM, Cohen FM, Kuwatsuru R, Neuder M, Mann JS, Vexler V, Muhler A, Rosenau W (1994) Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 29(Suppl. 2):8-11
4. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC (1994) Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Reson Med 31:1-8
5. Cohen FM, Kuwatsuru R, Shames DM, Neuder M, Mann JS, Vexler V, Rosenau W, Brasch RC (1994) Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol 29:970-977
6. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB (1997) Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32:741-747
7. Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S, Melnyk O (1997) Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 7:68-74
8. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H, Josephson L (1990) Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging. Radiology 175:489-493
9. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA (1994) AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 193:501-506
10. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM (2002) Iron-oxide-enhanced MR imaging of bone marrow with non-Hodgkin's lymphoma: Differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 12:1557-1566
11. Tavassoli M, Yoffey J (1983) Bone marrow structure and function. A.R. Liss, New York
12. Shirota T, Tavassoli M (1992) Alterations of bone marrow sinus endothelium induced by ionizing irradiatio: Implications in the homing of intravenously transplanted marrow cells. Blood Cells 18:197-214
13. Hudson G, Yoffey J (1968) Ultrastructure of reticuloendothelial elements in guinea pig bone marrow. J Anat 103:515-525
14. Daldrup H, Link T, Blasius S, Strozyk A, Könemann S, Jürgens H, Rummeny E (1999) Monitoring radiation induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI. J Magn Reson Imaging 9:643-652
15. Vande Berg BC, Lecouvet FE, Kanku JP, Jamart J, Van Beers BE, Maldague B, Malghem J (1999) Ferumoxides-enhanced quantitative magnetic resonance imaging of the normal and abnormal bone marrow: Preliminary assessment. J Magn Reson Imaging 9:322-328
16. Shirota T, Tavassoli M (1991) Cyclophosphamide-induced alterations of bone marrow endothelium: Implications in homing of marrow cells after transplantation. Exp Hematol 19:369-373
17. Harousseau JL, Shaughnessy J Jr, Richardson P (2004). Multiple myeloma. Hematology (Am Soc Hematol Educ Program) 237-256
18. Jung CW (1995) Surface properties of superparamagnetic iron oxide MR contrast agents: Ferrumoxides, ferrumoxtran, ferrumoxisil. Magn Res Imag 13:675-691
19. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C (1989) Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am J Roentgenol 152:167-173
20. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G (1993) Superparamagnetic iron oxides as positive contrast agents: In vitro and in vivo evidence. Magn Res Imag 11:509-519
21. Guimaraes R, Clement O, Bittoun J, Carnot F, Frija G (1993) MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. AJR 162:201-207
22. Brillet PY, Gazeau F, Luciani A, Bessoud B, Cuenod CA, Siauve N, Pons JN, Poupon J, Clement O (2005). Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: Comparative studies with ferumoxtran and anionic iron oxide nanoparticles. Eur Radiol 15:1369-1377
23. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE (2004). Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14:1851-1858
24. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC (1993) Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative non-invasive technique. Magn Reson Med 29:616-622
25. Iizuka-Mikami M, Nagai K, Yoshida K, Sugihara T, Suetsugu Y, Mikami M, Tamada T, Imai S, Kajihara Y, Fukunaga M (2004). Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: Comparison with bone and 67Ga scintigraphies. Eur Radiol 14:1074-1081